• G00110

• 2.4.1.-
• 2.4.1.62
• 2.4.3.2
• 2.4.3.8
• 2.4.3.9
• 3.2.1.18
• 3.2.1.23

• 15546874

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-acetyl
5b:b-dgal-HEX-1:5
6s:n-acetyl
7b:b-dgal-HEX-1:5
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:2o(4+1)5d
5:5d(2+1)6n
6:5o(3+1)7d

• Komagamine T et al. Ganglioside mimicry as a cause of Guillain-Barré syndrome. CNS Neurol Disord Drug Targets. 2006 Aug;5:(4):391-400. doi: 10.2174/187152706777950765. PMID: 16918391.

• Yuki N et al. Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome. J Neurol Sci. 1995 May;130:(1):112-6. doi: 10.1016/0022-510x(95)00045-4. PMID: 7544402.

• Iwamori M et al. Differential reactivities of fucosyl GM1 and GM1 gangliosides on rat erythrocyte membrane revealed by analysis with anti-fucosyl GM1 and GM1 antisera. J Biochem. 1983 Jul;94:(1):1-10. doi: 10.1093/oxfordjournals.jbchem.a134316. PMID: 6619101.

• Ravindranath MH et al. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324:(1):154-65. doi: 10.1016/j.bbrc.2004.09.029. PMID: 15464996.

• Kotani M et al. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 1995 Nov 27;700:(1-2):40-58. doi: 10.1016/0006-8993(95)00923-e. PMID: 8624728.

• Irie T et al. Analysis of gangliosides from carp intestinal mucosa. Fish Shellfish Immunol. 2004 Feb;16:(2):117-25. doi: 10.1016/S1050-4648(03)00046-9. PMID: 15123316.

• Watarai S et al. Establishment of monoclonal antibodies specific for ganglioside GM1: detection of ganglioside GM1 in small cell lung carcinoma cell lines and tissues. J Biochem. 1994 Nov;116:(5):948-54. doi: 10.1093/oxfordjournals.jbchem.a124651. PMID: 7896755.

• Kawashima I et al. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732:(1-2):75-86. doi: 10.1016/0006-8993(96)00493-3. PMID: 8891271.

• Yamazaki Y et al. Comprehensive analysis of monoclonal antibodies against detergent-insoluble membrane/lipid rafts of HL60 cells. J Immunol Methods. 2006 Apr 20;311:(1-2):106-16. doi: 10.1016/j.jim.2006.01.019. PMID: 16564536.

• Schnaar RL et al. Immunoglobulin G-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem. 2002 Mar 15;302:(2):276-84. doi: 10.1006/abio.2001.5540. PMID: 11878808.

• Townson K et al. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov;17:(11):1156-66. doi: 10.1093/glycob/cwm095. PMID: 17855742.

• Kotani M et al. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology. 1993 Apr;3:(2):137-46. doi: 10.1093/glycob/3.2.137. PMID: 8490240.

• Yuki N et al. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci U S A. 2004 Aug 3;101:(31):11404-9. doi: 10.1073/pnas.0402391101. PMID: 15277677.

• Hildebrandt H et al. Antigen binding of antiganglioside antibodies in vitro is strongly influenced by the ganglioside composition of the sample. FEBS Lett. 1996 Jun 10;388:(1):29-33. doi: 10.1016/0014-5793(96)00503-0. PMID: 8654583.

• Kotani M et al. Generation of one set of monoclonal antibodies specific for a-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jul 21;1117:(1):97-103. doi: 10.1016/0304-4165(92)90168-t. PMID: 1627599.

• Kusunoki S et al. Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve. 1993 Jul;16:(7):752-6. doi: 10.1002/mus.880160710. PMID: 7685064.